IMMUNIC, INC. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Immunic, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2024.
  • Immunic, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$25.7M, a 9.15% decline year-over-year.
  • Immunic, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$95.8M, a 28.1% increase year-over-year.
  • Immunic, Inc. annual Operating Income (Loss) for 2023 was -$99.2M, a 17% increase from 2022.
  • Immunic, Inc. annual Operating Income (Loss) for 2022 was -$119M, a 30.4% decline from 2021.
  • Immunic, Inc. annual Operating Income (Loss) for 2021 was -$91.7M, a 87.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.